I Sjaastad

First name:
I
Last name:
Sjaastad
Manotheepan, R., Danielsen, T. K., Sadredini, M., Anderson, M. E., Carlson, C. R., Lehnart, S. E., et al. (2016). Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release. Cardiovascular Research, 111(3), 295-306. https://doi.org/10.1093/cvr/cvw095 (Original work published 2016)
View
Lunde, I. G., Aronsen, J. M., Melleby, A. O., Strand, M. E., Skogestad, J., Bendiksen, B. A., et al. (2022). Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy. Molecular Biology Reports. https://doi.org/10.1007/s11033-022-07985-y (Original work published 2022)
View
Støle, T. P., Lunde, M., Shen, X., Martinsen, M., Lunde, P. K., Li, J., et al. The female syndecan-4-/- heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels.. Frontiers In Cell And Developmental Biology, 10, 908126. https://doi.org/10.3389/fcell.2022.908126 (Original work published 2022)
View
Carlson, C. R., Aronsen, J. M., Bergan-Dahl, A., Moutty, M. C., Lunde, M., Lunde, P. K., et al. (2022). AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR. Circulation Research, 130(1), 27-44. https://doi.org/10.1161/CIRCRESAHA.120.317976 (Original work published 2022)
View
Wanichawan, P., Skogestad, J., Lunde, M., Støle, T. P., Stensland, M., Nyman, T. A., et al. Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies.. Frontiers In Pharmacology, 12, 638646. https://doi.org/10.3389/fphar.2021.638646 (Original work published 2021)
View
Rønning, S. B., Carlson, C. R., Aronsen, J. M., Pisconti, A., Lunde, M., Liland, K. H., et al. Syndecan-4-/- Mice Have Smaller Muscle Fibers, Increased Akt/mTOR/S6K1 and Notch/HES-1 Pathways, and Alterations in Extracellular Matrix Components.. Frontiers In Cell And Developmental Biology, 8, 730. https://doi.org/10.3389/fcell.2020.00730 (Original work published 2020)
View
Herum, K. M., Romaine, A., Wang, A., Melleby, A. O., Strand, M. E., Pacheco, J., et al. (2020). Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin. Journal Of The American Heart Association, 9(3), e013518. https://doi.org/10.1161/JAHA.119.013518 (Original work published 2020)
View
Mathiesen, S. B., Lunde, M., Aronsen, J. M., Romaine, A., Kaupang, A., Martinsen, M., et al. (2019). The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP). The Journal Of Biological Chemistry, 294(22), 8717-8731. https://doi.org/10.1074/jbc.RA118.006423 (Original work published 2019)
View
Skogestad, J., Aronsen, J. M., Tovsrud, N., Wanichawan, P., Hougen, K., Stokke, M. K., et al. (2020). Coupling of the Na+/K+-ATPase to Ankyrin B controls Na+/Ca2+ exchanger activity in cardiomyocytes. Cardiovascular Research, 116(1), 78-90. https://doi.org/10.1093/cvr/cvz087 (Original work published 2020)
View
Ottesen, A. H., Carlson, C. R., Eken, O. S., Sadredini, M., Myhre, P. L., Shen, X., et al. (2019). Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.. Circulation. Arrhythmia And Electrophysiology, 12(4), e007045. https://doi.org/10.1161/CIRCEP.118.007045
View